Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Technique kills cancerous cells, leaves healthy cells intact

02.12.2003


Chemists at the University of Illinois at Urbana-Champaign have produced a molecule that selectively kills cancerous cells in a desired way and leaves healthy cells virtually untouched.



While encouraging, the findings don’t mean a new treatment is imminent. The basic laboratory experiments were done in microtiter dishes, where the compound was simply exposed to leukemia and lymphoma cells and healthy white blood cells from mice.

"It’s hard to say where this discovery may fit into the big picture, but the pathway we’ve found is real; it is very provocative," said Paul J. Hergenrother, a professor of chemistry, who directed the study funded by the National Science Foundation.


The study appears in the Dec. 3 issue of the Journal of the American Chemical Society. The compound, which is referred to as 13-D in the study, already is being tested by the National Cancer Institute. The University of Illinois has applied for a patent on it.

"The next big step would be to show that this compound works in an animal model," Hergenrother said. "We are very interested in the selectivity of this compound. We now are trying to track down exactly what protein target this compound is binding to in the cancer cells. If we can isolate the protein receptor, we may find a totally new anti-cancer target."

Hergenrother and his doctoral students Vitaliy Nesterenko and Karson S. Putt manufactured a library of 88 artificial compounds based on the structures of certain natural products. Three of the compounds showed a significant ability to kill cancer cells. Those three were further screened to determine if they were killing the cancer cells through apoptosis or necrosis.

Apoptosis is desired because cells die in a programmed fashion and are simply engulfed by other cells. Necrosis is essentially an accidental breakdown that results in the spilling of cellular material that triggers an undesirable anti-inflammatory response.

Compound 13-D was found to have the strongest cancer-killing effect and the only one to induce a cysteine protease known as caspase-3 as well as blebbing (a pinching off of the cellular membrane) and cell shrinkage, all of which are hallmarks of apoptosis.

"Once we had a compound that killed by apoptosis, we did the key experiment to see if the compound induced cell death selectively, choosing cancerous cells over non-cancerous white blood cells," Hergenrother said. "Compound 13-D showed virtually no toxicity toward the actively dividing T-cells while almost completely killing the lymphoma and leukemia cells."

Such results are desirable, because many current human therapeutic approaches result in undesired side effects such as anemia and major gastrointestinal problems.

Additionally, Hergenrother said, if the biological pathways can be isolated it may be possible to manufacture compounds that not only encourage apoptosis in cancer cells but also inhibit it in healthy cells, a potential benefit to sufferers of Alzheimer’s and Parkinson’s diseases in which many cells die off unnecessarily.

Jim Barlow | EurekAlert!
Further information:
http://www.uiuc.edu/

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>